CI - NYSE
Cigna Corporation
$270.73
-0.73%The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
At a Glance
Live SnapshotCigna Corporation Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
Cigna Corporation Income Statement
CI • NYSE
| Cigna Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
275B | 247.1B | 195.3B | 180.5B | 174.1B | 160.4B | 153.6B | 48.7B | 41.8B | 39.8B | 37.9B | 34.9B | 32.4B | 29.1B | 21.6B | 21.1B | 18.4B | 19.1B | 17.6B | 16.5B | |
GROSS PROFIT | ||||||||||||||||||||
(249B) | (221.2B) | (170.1B) | (157B) | (151.1B) | (136.2B) | (128.5B) | (32.3B) | (27.7B) | (26.8B) | (25.4B) | (23.2B) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
26B | 26B | 25.2B | 23.5B | 23B | 24.2B | 25.1B | 16.3B | 14.1B | 13B | 12.5B | 11.7B | 0.0 | 0.0 | 21.6B | 21.1B | 18.4B | 19.1B | 17.6B | 16.5B | |
OPERATING INCOME | ||||||||||||||||||||
(16.9B) | (16.5B) | (16.6B) | (15.1B) | (15B) | (16.1B) | (17B) | (12.2B) | (10.1B) | (9.9B) | (92M) | (85M) | (0.0) | (26.4B) | (19.8B) | (19.3B) | (16.5B) | (18.7B) | (16B) | (14.8B) | |
(14B) | (14.6B) | (14.3B) | (13B) | (12.8B) | (13.7B) | (13.3B) | (11.2B) | (9.8B) | (9.6B) | (92M) | (85M) | (0.0) | (0.0) | (5.9B) | (5.7B) | (5.3B) | (5.5B) | (4.7B) | (0.0) | |
9.1B | 9.4B | 8.5B | 8.5B | 7.9B | 8.2B | 8.1B | 4.2B | 3.9B | 3.1B | 12.4B | 11.6B | 32.4B | 2.9B | 1.9B | 1.8B | 1.9B | 382M | 1.6B | 1.7B | |
PRE-TAX INCOME | ||||||||||||||||||||
(1.4B) | (1.4B) | (1.4B) | (1.2B) | (1.2B) | (1.4B) | (1.7B) | (498M) | (252M) | (278M) | (0.0) | (0.0) | (264M) | (0.0) | (202M) | (182M) | (166M) | (0.0) | (0.0) | (0.0) | |
-1.4B | -1.4B | -1.4B | -1.2B | -1.2B | -1.4B | -1.7B | -498M | -252M | -278M | 0.0 | 0.0 | -264M | 0.0 | -202M | -182M | -166M | 0.0 | 0.0 | 0.0 | |
(2.9B) | (2B) | (2.3B) | (2B) | (2.2B) | (2.4B) | (3.7B) | (939M) | (299M) | (315M) | (0.0) | (0.0) | (0.0) | (0.0) | (13.9B) | (13.5B) | (11.2B) | (13.2B) | (11.3B) | (14.8B) | |
-1.5B | -4.1B | -3B | -53M | -1.2B | 2.7B | -1.5B | -579M | -336M | -109M | -9B | -8.3B | -30.2B | -398M | 0.0 | 3M | 0.0 | -421M | 0.0 | 0.0 | |
7.6B | 5.3B | 5.5B | 8.4B | 6.8B | 10.9B | 6.6B | 3.6B | 3.6B | 3B | 3.3B | 3.3B | 2.2B | 2.5B | 1.9B | 1.8B | 1.9B | 382M | 1.6B | 1.7B | |
NET INCOME | ||||||||||||||||||||
(1.3B) | (1.5B) | (141M) | (1.6B) | (1.4B) | (2.4B) | (1.5B) | (935M) | (1.4B) | (1.1B) | (1.3B) | (1.2B) | (698M) | (853M) | (615M) | (519M) | (594M) | (92M) | (511M) | (572M) | |
6B | 3.4B | 5.2B | 6.7B | 5.4B | 8.5B | 5.1B | 2.6B | 2.2B | 1.9B | 2.1B | 2.1B | 1.5B | 1.6B | 1.3B | 1.3B | 1.3B | 292M | 1.1B | 1.2B |
SEC Filings
CI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 13, 2026 | May 13, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 22, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 13, 2026 | April 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 03, 2026 | February 25, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 27, 2026 | February 27, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 18, 2025 | October 22, 2025 | 2025 |
Related Guides
Continue your CI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.